腺癌
基因型
克拉斯
癌变
生物
表型
细胞培养
癌症研究
胰腺癌
细胞
癌症
基因
生物信息学
遗传学
突变
作者
Emily L. Deer,Jessica González-Hernández,Jill D. Coursen,Jill E. Shea,Josephat Ngatia,Courtney L. Scaife,Matthew A. Firpo,Sean J. Mulvihill
出处
期刊:Pancreas
[Ovid Technologies (Wolters Kluwer)]
日期:2010-05-01
卷期号:39 (4): 425-435
被引量:731
标识
DOI:10.1097/mpa.0b013e3181c15963
摘要
The dismal prognosis of pancreatic adenocarcinoma is due in part to a lack of molecular information regarding disease development. Established cell lines remain a useful tool for investigating these molecular events. Here we present a review of available information on commonly used pancreatic adenocarcinoma cell lines as a resource to help investigators select the cell lines most appropriate for their particular research needs. Information on clinical history; in vitro and in vivo growth characteristics; phenotypic characteristics, such as adhesion, invasion, migration, and tumorigenesis; and genotypic status of commonly altered genes (KRAS, p53, p16, and SMAD4) was evaluated. Identification of both consensus and discrepant information in the literature suggests careful evaluation before selection of cell lines and attention be given to cell line authentication.
科研通智能强力驱动
Strongly Powered by AbleSci AI